229. The SND proteins constitute an alternative targeting route to the endoplasmic reticulum.
作者: Naama Aviram.;Tslil Ast.;Elizabeth A Costa.;Eric C Arakel.;Silvia G Chuartzman.;Calvin H Jan.;Sarah Haßdenteufel.;Johanna Dudek.;Martin Jung.;Stefan Schorr.;Richard Zimmermann.;Blanche Schwappach.;Jonathan S Weissman.;Maya Schuldiner.
来源: Nature. 2016年540卷7631期134-138页
In eukaryotes, up to one-third of cellular proteins are targeted to the endoplasmic reticulum, where they undergo folding, processing, sorting and trafficking to subsequent endomembrane compartments. Targeting to the endoplasmic reticulum has been shown to occur co-translationally by the signal recognition particle (SRP) pathway or post-translationally by the mammalian transmembrane recognition complex of 40 kDa (TRC40) and homologous yeast guided entry of tail-anchored proteins (GET) pathways. Despite the range of proteins that can be catered for by these two pathways, many proteins are still known to be independent of both SRP and GET, so there seems to be a critical need for an additional dedicated pathway for endoplasmic reticulum relay. We set out to uncover additional targeting proteins using unbiased high-content screening approaches. To this end, we performed a systematic visual screen using the yeast Saccharomyces cerevisiae, and uncovered three uncharacterized proteins whose loss affected targeting. We suggest that these proteins work together and demonstrate that they function in parallel with SRP and GET to target a broad range of substrates to the endoplasmic reticulum. The three proteins, which we name Snd1, Snd2 and Snd3 (for SRP-independent targeting), can synthetically compensate for the loss of both the SRP and GET pathways, and act as a backup targeting system. This explains why it has previously been difficult to demonstrate complete loss of targeting for some substrates. Our discovery thus puts in place an essential piece of the endoplasmic reticulum targeting puzzle, highlighting how the targeting apparatus of the eukaryotic cell is robust, interlinked and flexible.
232. Stem cells and interspecies chimaeras.
作者: Jun Wu.;Henry T Greely.;Rudolf Jaenisch.;Hiromitsu Nakauchi.;Janet Rossant.;Juan Carlos Izpisua Belmonte.
来源: Nature. 2016年540卷7631期51-59页
Chimaeras are both monsters of the ancient imagination and a long-established research tool. Recent advances, particularly those dealing with the identification and generation of various kinds of stem cells, have broadened the repertoire and utility of mammalian interspecies chimaeras and carved out new paths towards understanding fundamental biology as well as potential clinical applications.
238. Consistency in drug response profiling.
作者: John Patrick Mpindi.;Bhagwan Yadav.;Päivi Östling.;Prson Gautam.;Disha Malani.;Astrid Murumägi.;Akira Hirasawa.;Sara Kangaspeska.;Krister Wennerberg.;Olli Kallioniemi.;Tero Aittokallio.
来源: Nature. 2016年540卷7631期E5-E6页 240. Drug response consistency in CCLE and CGP.
作者: Mehdi Bouhaddou.;Matthew S DiStefano.;Eric A Riesel.;Emilce Carrasco.;Hadassa Y Holzapfel.;DeAnalisa C Jones.;Gregory R Smith.;Alan D Stern.;Sulaiman S Somani.;T Victoria Thompson.;Marc R Birtwistle.
来源: Nature. 2016年540卷7631期E9-E10页 |